Prometrium combined with Provera

Reports:

Reaction Outcome Event Date Age Sex Weight Reported Reporter Country Treatment
Role Name
Psychotic Disorder Hospitalization 8/25/2005 Female 1/9/2006 Physician United States
Primary
Secondary
Concomitant
Psychotic Disorder Hospitalization 8/25/2005 Female 1/31/2006 Physician United States
Primary
Secondary
Concomitant
Breast Cancer Female Other Serious Female 1/26/2006 United States
Primary
Secondary
Breast Cancer Other Serious 12/5/2001 49 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 10/4/2002 Female 12/23/2005 United States
Primary
Secondary
Concomitant
Breast Cancer Other Serious 10/1/2001 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 2/28/2002 52 Female 142 lb 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 1/7/2003 47 Female 12/23/2005 United States
Primary
Secondary
Vision Blurred Hospitalization Female 150 lb 2/21/2006 Pharmacist United States
Primary
Secondary
Concomitant
Breast Cancer Other Serious 3/1/2002 59 Female 130 lb 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 1/25/2002 Female 2/28/2006 Consumer United States
Primary
Secondary
Breast Cancer Female Other Serious 1/25/2002 Female 3/1/2006 United States
Primary
Secondary
Breast Cancer Other Serious 8/5/2004 68 Female 3/15/2006 Lawyer United States
Primary
Secondary
Skin Cancer Other Serious 8/29/2003 55 Female 3/10/2006 United States
Primary
Secondary
Vision Blurred Hospitalization Female 150 lb 3/23/2006 Pharmacist United States
Primary
Secondary
Concomitant
Progesterone Receptor Assay Positive Other Serious 8/5/2004 68 Female 3/17/2006 United States
Primary
Secondary
Vision Blurred Hospitalization Female 150 lb 3/28/2006 Pharmacist United States
Primary
Secondary
Concomitant
Progesterone Receptor Assay Positive Other Serious 8/5/2004 68 Female 3/20/2006 United States
Primary
Secondary
Myocardial Infarction Hospitalization 12/4/2003 63 Female 154 lb 4/10/2006 Lawyer United States
Primary
Concomitant
Vision Blurred Hospitalization Female 150 lb 4/11/2006 Pharmacist United States
Primary
Secondary
Concomitant
Breast Cancer Other Serious 1/7/2003 47 Female 2/9/2006 Consumer United States
Primary
Secondary
Breast Cancer Other Serious 9/1/2002 66 Female 2/8/2006 Consumer United States
Primary
Secondary
Breast Cancer Other Serious 1/1/2004 63 Female 2/8/2006 United States
Primary
Secondary
Breast Cancer Other Serious 10/1/2001 Female 2/8/2006 Consumer United States
Primary
Secondary
Breast Cancer Other Serious 10/4/2002 Female 2/8/2006 Consumer United States
Primary
Secondary
Vision Blurred Hospitalization Female 150 lb 4/19/2006 Pharmacist United States
Primary
Secondary
Concomitant
Metastases To Lymph Nodes Other Serious 6/27/2002 63 Female 130 lb 4/13/2006 United States
Primary
Secondary
Concomitant
Neoplasm Malignant Other Serious 12/14/1995 54 Female 190 lb 4/18/2006 Physician United States
Primary
Secondary
Concomitant
Progesterone Receptor Assay Positive Other Serious 4/9/2002 67 Female 4/20/2006 United States
Primary
Secondary
Vision Blurred Hospitalization Female 150 lb 5/1/2006 Pharmacist United States
Primary
Secondary
Concomitant
Breast Cancer Female Other Serious 2/6/2002 64 Female 4/26/2006 United States
Primary
Secondary
Progesterone Receptor Assay Positive Other Serious 4/11/2003 64 Female 5/25/2006 United States
Primary
Secondary
Progesterone Receptor Assay Positive Other Serious 5/31/2000 58 Female 5/30/2006 United States
Primary
Secondary
Breast Cancer Other Serious 10/1/2001 Female 6/8/2006 Consumer United States
Primary
Secondary
Breast Cancer Other Serious 1/1/2003 Female 7/12/2006 Lawyer United States
Primary
Secondary
Vision Blurred Hospitalization Female 150 lb 7/19/2006 Pharmacist United States
Primary
Secondary
Concomitant
Breast Cancer Female Other Serious 1/1/2003 Female 7/17/2006 United States
Primary
Secondary
Breast Cancer Female Other Serious 1/8/1999 Female 7/21/2006 United States
Primary
Secondary
Breast Cancer Female Other Serious 1/8/1999 Female 7/21/2006 Lawyer United States
Primary
Secondary
Breast Cancer Required Intervention Female 6/15/2006 Lawyer United States
Primary
Secondary
Vision Blurred Hospitalization Female 150 lb 8/3/2006 Pharmacist United States
Primary
Secondary
Concomitant
Breast Cancer Other Serious 10/20/2004 59 Female 8/8/2006 Consumer United States
Primary
Secondary
Progesterone Receptor Assay Positive Other Serious 9/23/2002 70 Female 8/18/2006 Lawyer United States
Primary
Secondary
Progesterone Receptor Assay Positive Other Serious 10/20/2004 59 Female 8/21/2006 United States
Primary
Secondary
Breast Cancer Female Other Serious 8/20/2004 63 Female 9/22/2006 United States
Primary
Secondary
Breast Cancer Female Other Serious 11/1/2002 Female 10/4/2006 Lawyer United States
Primary
Secondary
Breast Cancer Female Other Serious 11/1/2002 Female 10/13/2006 United States
Primary
Secondary
Breast Cancer In Situ Other Serious 6/28/2004 47 Female 10/31/2006 United States
Primary
Secondary
Ovarian Cancer Other Serious 11/19/2003 Female 11/14/2006 Lawyer United States
Primary
Secondary
Ovarian Cancer Other Serious 11/19/2003 Female 11/15/2006 Lawyer United States
Primary
Secondary
Breast Cancer Female Other Serious 6/18/2003 63 Female 11/28/2006 Lawyer United States
Primary
Secondary
Breast Cancer Female Other Serious 12/1/2002 Female 12/15/2006 Lawyer United States
Primary
Secondary
Breast Cancer Other Serious 5/31/2000 58 Female 10/10/2006 United States
Primary
Secondary
Breast Cancer Other Serious 1/25/2002 Female 10/10/2006 United States
Primary
Secondary
Breast Cancer Other Serious 9/23/2002 70 Female 10/10/2006 United States
Primary
Secondary
Breast Cancer Other Serious 8/20/2004 63 Female 10/10/2006 United States
Primary
Secondary
Breast Cancer Other Serious 1/1/2003 Female 10/10/2006 United States
Primary
Secondary
Breast Cancer Other Serious 10/20/2004 59 Female 1/12/2007 Lawyer United States
Primary
Secondary
Breast Cancer In Situ Other Serious 4/9/2002 67 Female 10/10/2006 United States
Primary
Secondary
Breast Cancer Other Serious 1/8/1999 Female 10/10/2006 United States
Primary
Secondary
Breast Cancer In Situ Other Serious 6/28/2004 47 Female 10/10/2006 United States
Primary
Secondary
Ovarian Cancer Metastatic Other Serious 2/4/2002 55 Female 173 lb 10/10/2006 United States
Primary
Secondary
Concomitant
Death Other Serious 10/20/2004 59 Female 1/18/2007 Consumer United States
Primary
Secondary
Injury Other Serious 10/1/2001 Female 9/18/2006 Lawyer United States
Primary
Secondary
Scar Other Serious 10/26/2001 Female 9/18/2006 Lawyer United States
Primary
Secondary
Breast Cancer Female Other Serious 3/1/2001 Female 2/22/2007 Lawyer United States
Primary
Secondary
Breast Cancer Female Other Serious 3/1/2001 Female 2/22/2007 United States
Primary
Secondary
Uterine Leiomyoma Other Serious 1/15/1999 67 Female 138 lb 3/1/2007 United States
Primary
Secondary
Concomitant
Uterine Leiomyoma Other Serious 1/15/1999 67 Female 138 lb 3/1/2007 United States
Primary
Secondary
Concomitant
Breast Cancer Metastatic Other Serious 4/3/2001 Female 3/7/2007 Lawyer United States
Primary
Secondary
Breast Cancer Other Serious 11/1/2001 Female 3/26/2007 Lawyer United States
Primary
Secondary
Breast Cancer Female Other Serious 11/1/2001 Female 3/20/2007 Lawyer United States
Primary
Secondary
Mastectomy Other Serious 1/25/2002 Female 11/3/2006 Lawyer United States
Primary
Secondary
Wound Necrosis Other Serious 2/19/2001 58 Female 112 lb 4/5/2007 United States
Primary
Secondary
Concomitant
Breast Cancer Other Serious 2/14/2001 47 Female 12/22/2006 United States
Primary
Secondary
Breast Cancer Other Serious 10/29/2001 50 Female 118 lb 12/22/2006 United States
Primary
Secondary
Breast Cancer In Situ Other Serious 3/18/2002 59 Female 125 lb 12/22/2006 United States
Primary
Secondary
Breast Cancer Other Serious 1/1/2003 Female 12/22/2006 United States
Primary
Secondary
Ovarian Cancer Other Serious 11/19/2003 Female 12/22/2006 United States
Primary
Secondary
Breast Cancer Other Serious 2/6/2002 64 Female 12/22/2006 United States
Primary
Secondary
Breast Cancer Other Serious 8/5/2004 68 Female 12/22/2006 United States
Primary
Secondary
Breast Cancer Other Serious 4/11/2003 64 Female 1/31/2007 United States
Primary
Secondary
Breast Cancer Other Serious 1/1/2003 Female 1/31/2007 Other Health Professional United States
Primary
Secondary
Breast Cancer Other Serious 1/8/1999 Female 1/31/2007 Consumer United States
Primary
Secondary
Breast Cancer Death 10/20/2004 59 Female 1/31/2007 Consumer United States
Primary
Secondary
Breast Cancer Other Serious 9/23/2002 70 Female 1/31/2007 Consumer United States
Primary
Secondary
Breast Cancer Other Serious Female 1/31/2007 Consumer United States
Primary
Secondary
Breast Cancer Other Serious 1/25/2002 Female 1/31/2007 Consumer United States
Primary
Secondary
Breast Cancer Other Serious 12/5/2001 Female 1/31/2007 Consumer United States
Primary
Secondary
Breast Cancer In Situ Other Serious 1/1/2002 67 Female 1/31/2007 Consumer United States
Primary
Secondary
Breast Cancer Other Serious Female 1/31/2007 Consumer United States
Primary
Secondary
Breast Cancer Other Serious 1/1/2004 68 Female 1/31/2007 Consumer United States
Primary
Secondary
Breast Cancer Other Serious 1/1/2000 58 Female 1/31/2007 Consumer United States
Primary
Secondary
Breast Cancer Female Other Serious 2/1/2001 Female 4/18/2007 Lawyer United States
Primary
Secondary
Breast Cancer Other Serious 8/20/2004 63 Female 1/31/2007 United States
Primary
Secondary
Ovarian Cancer Other Serious 11/19/2003 Female 1/31/2007 United States
Primary
Secondary
Breast Cancer Other Serious 11/1/2002 Female 1/31/2007 United States
Primary
Secondary
Breast Cancer Other Serious 12/1/2002 Female 1/31/2007 Consumer United States
Primary
Secondary
Tricuspid Valve Incompetence Other Serious 6/3/2003 64 Female 150 lb 4/24/2007 United States
Primary
Secondary
Concomitant
Breast Cancer In Situ Other Serious 12/27/2001 56 Female 138 lb 2/7/2007 Physician United States
Primary
Secondary
Uterine Prolapse Other Serious 1/1/1994 56 Female 7/18/2007 United States
Primary
Secondary
Breast Cancer Required Intervention 4/2/2003 55 Female 171 lb 7/5/2007 Consumer United States
Primary
Secondary
Concomitant
Breast Cancer Metastatic Other Serious 11/5/2002 Female 8/8/2007 Consumer United States
Primary
Secondary
Breast Cancer Other Serious 11/1/2002 Female 8/21/2007 Consumer United States
Primary
Secondary
Breast Cancer Other Serious 10/20/2004 57 Female 8/21/2007 Consumer United States
Primary
Secondary
Breast Cancer Other Serious 3/1/2001 Female 8/21/2007 Consumer United States
Primary
Secondary
Uterine Cancer Other Serious 9/5/2007 57 Female 10/15/2007 Physician United States
Primary
Concomitant
Breast Cancer Other Serious 6/18/2003 63 Female 10/12/2007 United States
Primary
Secondary
Breast Cancer Other Serious 11/1/2001 Female 10/12/2007 United States
Primary
Secondary
Breast Cancer Other Serious 11/1/2002 Female 10/12/2007 United States
Primary
Secondary
Tricuspid Valve Incompetence Other Serious 6/3/2003 64 Female 150 lb 11/15/2007 United States
Primary
Secondary
Concomitant
Breast Cancer Other Serious 12/1/2002 Female 9/17/2007 Lawyer United States
Primary
Secondary
Uterine Leiomyoma Other Serious 1/1/1993 59 Female 165 lb 9/17/2007 Lawyer United States
Primary
Secondary
Concomitant
Metrorrhagia Other Serious 12/1/1994 55 Female 9/17/2007 Lawyer United States
Primary
Secondary
Concomitant
Haematoma Other Serious 6/15/2004 Female 158 lb 1/8/2008 Consumer United States
Primary
Secondary
Breast Cancer In Situ Other Serious 12/27/2001 57 Female 139 lb 1/10/2008 Physician United States
Primary
Secondary
Concomitant
Uterine Prolapse Other Serious 1/1/1994 56 Female 1/10/2008 United States
Primary
Secondary
Breast Cancer Other Serious 1/28/2003 47 Female 12/18/2007 United States
Primary
Secondary
Breast Cancer Other Serious 3/1/2003 57 Female 12/18/2007 United States
Primary
Secondary
Breast Cancer Other Serious 12/1/2002 Female 12/18/2007 United States
Primary
Secondary
Breast Cancer Other Serious 2/1/2001 Female 12/18/2007 United States
Primary
Secondary
Breast Cancer Other Serious 6/16/1998 66 Female 12/18/2007 United States
Primary
Secondary
Breast Cancer Other Serious 56 Female 12/18/2007 Lawyer United States
Primary
Secondary
Breast Cancer Other Serious 9/18/2000 59 Female 12/18/2007 United States
Primary
Secondary
Breast Cancer Other Serious 10/29/2001 50 Female 118 lb 12/18/2007 United States
Primary
Secondary
Breast Cancer Other Serious 10/22/2001 54 Female 120 lb 12/18/2007 United States
Primary
Secondary
Concomitant
Breast Cancer Other Serious 3/1/2002 59 Female 130 lb 12/18/2007 United States
Primary
Secondary
Breast Cancer Metastatic Other Serious 8/29/2003 Female 2/14/2008 Lawyer United States
Primary
Secondary
Breast Cancer Metastatic Other Serious 3/19/2003 Female 154 lb 2/20/2008 Consumer United States
Primary
Secondary
Breast Cancer Metastatic Other Serious 2/6/2002 Female 2/27/2008 Consumer United States
Primary
Secondary
Breast Cancer Metastatic Other Serious 6/27/2002 Female 130 lb 3/3/2008 Consumer United States
Primary
Secondary
Concomitant
Breast Cancer Other Serious 3/1/2001 Female 1/31/2008 Consumer United States
Primary
Secondary
Breast Cancer Other Serious 11/1/2001 Female 1/31/2008 Consumer United States
Primary
Secondary
Breast Cancer Other Serious 2/1/2001 Female 1/31/2008 Consumer United States
Primary
Secondary
Breast Cancer Other Serious 4/27/2003 64 Female 1/31/2008 Consumer United States
Primary
Secondary
Breast Cancer Death 10/20/2004 59 Female 1/31/2008 Consumer United States
Primary
Secondary
Breast Cancer Recurrent Other Serious 10/14/1999 Female 3/13/2008 Consumer United States
Primary
Secondary
Breast Cancer Metastatic Other Serious 3/21/2003 Female 4/4/2008 Lawyer United States
Primary
Secondary
White Blood Cell Count Decreased Other Serious 1/1/1994 56 Female 157 lb 4/8/2008 United States
Primary
Secondary
Concomitant
Tricuspid Valve Incompetence Other Serious 6/3/2003 64 Female 150 lb 4/21/2008 United States
Primary
Secondary
Concomitant
Breast Cancer Metastatic Other Serious 6/16/1998 Female 4/24/2008 Lawyer United States
Primary
Secondary
Breast Cancer Metastatic Other Serious 8/29/2003 Female 5/5/2008 Lawyer United States
Primary
Secondary
Breast Cancer Metastatic Other Serious 10/25/2002 Female 5/8/2008 Consumer United States
Primary
Secondary
Breast Cancer Metastatic Other Serious 7/25/2001 Female 5/9/2008 Lawyer United States
Primary
Secondary
Breast Cancer Metastatic Other Serious 4/13/1999 Female 195 lb 5/22/2008 Consumer United States
Primary
Secondary
Breast Cancer Metastatic Other Serious 4/13/1999 Female 195 lb 6/13/2008 Consumer United States
Primary
Secondary
White Blood Cell Count Decreased Other Serious 1/1/1994 Female 157 lb 6/19/2008 United States
Primary
Secondary
Concomitant
Haematoma Other Serious 6/15/2004 Female 158 lb 6/23/2008 Consumer United States
Primary
Secondary
Breast Cancer Female Other Serious Female 6/24/2008 Consumer United States
Primary
Secondary
Breast Cancer Female Death Female 6/25/2008 United States
Primary
Secondary

Drug Data